| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002013 | American Journal of Ophthalmology | 2014 | 9 Pages |
Abstract
The frequency of anti-VEGF injections for neovascular AMD was lower than that recommended by large-scale clinical trials, and rates of discontinuation were high. National practice patterns in anti-VEGF therapy for patients with neovascular AMD do not reflect optimal treatment strategies suggested by recent clinical trial evidence.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Eleonora M. Lad, Bradley G. Hammill, Laura G. Qualls, Fang Wang, Scott W. Cousins, Lesley H. Curtis,